GlassScriptPhysician profile
Margaret Beaudrot
NPI 1083971550
$5,151.56
in general payments reported to CMS, 2019-2025
34 companies · $770 in 2025
The $770 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $173 · 2021: $1,261 · 2022: $1,178 · 2023: $869 · 2024: $465 · 2025: $770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,103.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,426.54 | 2019-2024 | Lo Loestrin Fe, Qulipta, Orilissa |
| Exeltis, USA INC. | $605.59 | 2020-2025 | Slynd |
| Aspira Women'S Health INC | $362.41 | 2021-2024 | Ova1 |
| Mayne Pharma Commercial LLC | $296.78 | 2022-2025 | |
| Astellas Pharma US INC | $262.30 | 2021-2025 | Veozah |
| Myovant Sciences INC. | $248.80 | 2021-2022 | |
| Sage Therapeutics, LLC | $204.28 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $198.60 | 2023-2025 | Myfembree |
| Daiichi Sankyo INC. | $173.37 | 2021-2023 | Injectafer |
| Boston Scientific Corporation | $156.01 | 2023-2025 | General - Female Sui, Axonics, Advantage System |
| Medical Device Business Services, INC. | $141.59 | 2019 | |
| Avion Pharmaceuticals | $103.91 | 2019-2023 | Balcoltra |
| Gen-Probe Sales & Service, INC. | $89.24 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $80.40 | 2019-2025 | |
| Organon LLC | $78.57 | 2022-2025 | Nexplanon |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $76.74 | 2024-2025 | |
| Ethicon US, LLC | $69.89 | 2019-2021 | |
| Hologic Sales and Service, LLC | $58.93 | 2019-2022 | |
| Medtronic, INC. | $55.68 | 2021-2022 | |
| Channel Medsystems, INC. | $51.91 | 2022 | |
| Agile Therapeutics, INC. | $48.75 | 2021-2022 | |
| Axonics, INC. | $40.56 | 2021-2024 | Axonics, Bulkamid |
| Becton, Dickinson and Company | $36.37 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $35.29 | 2025 | Qelbree |
| Evofem Biosciences, INC. | $32.94 | 2020-2021 | |
| Therapeuticsmd, INC. | $30.95 | 2021 | |
| Olympus America INC. | $30.40 | 2024 | Shockpulse |
| Duchesnay USA Incorporated | $28.14 | 2019 | |
| Urovant Sciences INC | $27.76 | 2022 | |
| Mylan Pharmaceuticals INC. | $25.18 | 2019 | |
| Merck Sharp & Dohme LLC | $22.18 | 2019 | |
| Millicent US INC | $20.68 | 2024 | Intrarosa |
| Coopersurgical, INC. | $18.56 | 2024 | Summit Doppler |
| Amgen INC. | $12.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Beaudrot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.